Imapextide
CLevel 1 evidenceImapextide
Basic Information
Long-acting GLP-1 receptor antagonist
MBX Biosciences: Weekly GLP-1 Receptor Antagonist for Investigational Use; Addresses Post-Bariatric Hypoglycemia; Long-acting Competitor to Avexitide.
Efficacy Rating
Class C
No data available
No data available
China Regulatory Status
No data available
No data available
No data available
Similar Peptide Recommendations
ASC30
ASC30
Research, GLP-1, small molecules
Avexitide
Avexitide
Research, GLP-1 antagonists, hypoglycemia
Berobenatide
Berobenatide
GLP-1, Weight Loss, Obesity
DA-1726
DA-1726
Research, Weight Loss, GLP-1
Disclaimer
The content on this platform is for educational and informational purposes only and does not constitute medical advice, formulation guidance, or a guarantee of regulatory compliance. All efficacy claims are labeled with their evidence level; please consult a professional before making any decisions.